Showing results (2301-2310 of 2,376) with videos related to
Sort By:
Pageof 238
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Novel tricyclic pyrazolopyrimidines as potent and selective GPR119 agonistsMihai Azimioara, Phil Alper, Christopher Cow, et al.Plos One|June 30, 2015
Inhibition of the Inositol Kinase Itpkb Augments Calcium Signaling in Lymphocytes and Reveals a Novel Strategy to Treat Autoimmune DiseaseAndrew T Miller, Carol Dahlberg, Mark L Sandberg, et al.Science (New York, N.Y.)|March 28, 2024
BCG vaccination reduces bovine tuberculosis transmission, improving prospects for eliminationAbebe Fromsa, Katriina Willgert, Sreenidhi Srinivasan, et al.Molecular Psychiatry|February 22, 2017
Partitioning heritability analysis reveals a shared genetic basis of brain anatomy and schizophreniaP H Lee, J T Baker, A J Holmes, et al.Clinical Pharmacology and Therapeutics|January 21, 2019
Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen AllelesPaola Nicoletti, Guruprasad P Aithal, Thomas C Chamberlain, et al.Scientific Reports|February 6, 2025
Comparative performance of tuberculin and defined-antigen cocktails for detecting bovine tuberculosis in BCG-vaccinated cattle in natural settingsAbebe Fromsa, Andrew J K Conlan, Sreenidhi Srinivasan, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Potent small molecule CCR1 antagonistsJohn C Kath, William H Brissette, Matthew F Brown, et al.Journal of Global Health|August 4, 2025
Development of an innovative, competency-based, multi-speciality training programme in global health for graduate medical educationElizabeth S Rose, Rondi M Kauffmann, Marie H Martin, et al.Journal of Medicinal Chemistry|September 12, 2014
Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt diseaseChristopher L Cioffi, Nicoleta Dobri, Emily E Freeman, et al.Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Benzimidazolone p38 inhibitorsMark A Dombroski, Michael A Letavic, Kim F McClure, et al.Pageof 238